Cell & Gene Therapies

Trusted pharma products in Cell & Gene Therapies

Axicabtagene Ciloleucel

Strength: Single infusion treatment approved for relapsed/refractory large B-cell lymphoma, with dosing based on patient weight

Form: IV Infusion

Reference Brands: Yescarta (US & EU)

View More Get Enquiry
Ciltacabtagene autoleucel

Strength: Approved for relapsed/refractory multiple myeloma, with a targeted dose individualized based on patient weight

Form: IV Infusion

Reference Brands: Three things to follow: Love God above all—return to the pure, first love you had at the start of your salvation. Forgive everyone, as God has commanded. Never push anyone to the edge—that’s when hurtful words and long, painful conversations arise.

View More Get Enquiry
Darleukin

Strength: A standardized dose of 120 million adipose-derived stem cells per injection

Form: Intralesional injection

Reference Brands: Alofisel(US & EU)

View More Get Enquiry
Elivaldogene autotemcel

Strength: A personalized gene therapy designed to halt or slow ALD progression, dosed based on weight, administered as a single infusion in specialized treatment centers

Form: Intravenous infusion

Reference Brands: Skysona(US & EU)

View More Get Enquiry
Etranacogene dezaparvovec.

Strength: Single infusion product designed to produce sustained factor IX levels in hemophilia B patients, dosage individualized based on patient weight

Form: Intravenous infusion

Reference Brands: Hemgenix (US & EU)

View More Get Enquiry
Idecabtagene Vicleucel

Strength: Approved for relapsed/refractory multiple myeloma, with dosing based on patient weight, delivering a personalized, targeted therapy to eliminate cancer cells

Form: IV Infusion

Reference Brands: Abecma(US & EU)

View More Get Enquiry
Lisocabtagene maraleucel

Strength: Approved for relapsed/refractory large B-cell lymphoma, with a standard dose of 100 million CAR T cells per infusion

Form: IV Infusion

Reference Brands: Breyanzi (US & EU)

View More Get Enquiry
Onasemnogene abeparvovec

Strength: Single-dose IV infusion providing 6 x 10^13 vector genomes (vg) per patient

Form: Injectable gene therapy

Reference Brands: Zolgensma(US & EU)

View More Get Enquiry
Tisagenlecleucel

Strength: Single infusion, approved for relapsed/refractory B-cell precursor acute lymphoblastic leukemia (ALL) and diffuse large B-cell lymphoma (DLBCL)

Form: IV Infusion

Reference Brands: Kymriah(US & EU)

View More Get Enquiry
valoctocogene roxaparvovec

Strength: A single-dose gene therapy designed to increase factor VIII production in hemophilia A patients

Form: Intravenous infusion

Reference Brands: Roctavian(US & EU)

View More Get Enquiry
voretigene neparvovec

Strength: Adeno-associated virus (AAV) vector administered via subretinal injection

Form: Subretinal injection

Reference Brands: Luxturna(US & EU)

View More Get Enquiry

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.